v3.25.3
Condensed Consolidated Statements of Stockholders' (Deficit) Equity - USD ($)
$ in Thousands
Preferred Stock
Common stock
Additional paid-in capital
Accumulated other comprehensive income / (loss)
Accumulated deficit
Total
Beginning Balance at Dec. 31, 2023     $ 104,757 $ (1,578) $ (95,066) $ 8,113
Beginning Balance (in shares) at Dec. 31, 2023 13,765 889,668        
Stock-based compensation expense     107     107
Issuance of stock awards     21     21
Issuance of stock awards (in Shares)   3,400        
Issuance of common stock to vendor     53     53
Issuance of common stock to vendor (in shares)   50,000        
Conversion of Preferred stock into common stock (in shares) (3,817) (436,294)        
Exchange of Preferred stock into common stock warrants (in shares) (6,356)          
Deemed dividend on extinguishment of Preferred stock     7,069   (7,094) (25)
Exercise of warrants into common stock (in shares)   388        
Foreign currency translation adjustment       (18)   (18)
Net loss         (1,696) (1,696)
Ending Balance at Mar. 31, 2024     112,007 (1,596) (103,856) 6,555
Ending Balance (in shares) at Mar. 31, 2024 3,592 1,379,750        
Beginning Balance at Dec. 31, 2023     104,757 (1,578) (95,066) 8,113
Beginning Balance (in shares) at Dec. 31, 2023 13,765 889,668        
Foreign currency translation adjustment           281
Net loss           (7,637)
Ending Balance at Sep. 30, 2024     113,374 (1,297) (109,797) 2,280
Ending Balance (in shares) at Sep. 30, 2024 856 1,780,472        
Beginning Balance at Mar. 31, 2024     112,007 (1,596) (103,856) 6,555
Beginning Balance (in shares) at Mar. 31, 2024 3,592 1,379,750        
Stock-based compensation expense     207     207
Issuance of common stock to vendor     48     48
Issuance of common stock to vendor (in shares)   50,000        
Conversion of Preferred stock into common stock (in shares) (2,486) (284,150)        
Exercise of warrants into common stock     3     3
Exercise of warrants into common stock (in shares)   8,000        
Fair value of warrants reclassified from liability to equity     700     700
Foreign currency translation adjustment       174   174
Net loss         (3,099) (3,099)
Ending Balance at Jun. 30, 2024     112,965 (1,422) (106,955) 4,588
Ending Balance (in shares) at Jun. 30, 2024 1,106 1,721,900        
Stock-based compensation expense     257     257
Issuance of common stock to vendor     152     152
Issuance of common stock to vendor (in shares)   30,000        
Conversion of Preferred stock into common stock (in shares) (250) 28,572        
Foreign currency translation adjustment       125   125
Net loss         (2,842) (2,842)
Ending Balance at Sep. 30, 2024     113,374 (1,297) (109,797) 2,280
Ending Balance (in shares) at Sep. 30, 2024 856 1,780,472        
Beginning Balance at Dec. 31, 2024     122,316 (1,105) (114,620) 6,591
Beginning Balance (in shares) at Dec. 31, 2024 856 3,590,217        
Stock-based compensation expense     250     250
Issuance of common stock to vendor     85     85
Issuance of common stock to vendor (in shares)   30,000        
Foreign currency translation adjustment       (1,005)   (1,005)
Net loss         (2,134) (2,134)
Ending Balance at Mar. 31, 2025     122,651 (2,110) (116,754) 3,787
Ending Balance (in shares) at Mar. 31, 2025 856 3,620,217        
Beginning Balance at Dec. 31, 2024     122,316 (1,105) (114,620) $ 6,591
Beginning Balance (in shares) at Dec. 31, 2024 856 3,590,217        
Issuance of common stock to vendor (in shares)           190,000
Foreign currency translation adjustment           $ (2,269)
Net loss           (8,454)
Ending Balance at Sep. 30, 2025   $ 1 123,495 (3,374) (123,074) (2,952)
Ending Balance (in shares) at Sep. 30, 2025   5,605,043        
Beginning Balance at Mar. 31, 2025     122,651 (2,110) (116,754) 3,787
Beginning Balance (in shares) at Mar. 31, 2025 856 3,620,217        
Stock-based compensation expense     260     260
Issuance of common stock to vendor     290     290
Issuance of common stock to vendor (in shares)   130,000        
Conversion of Preferred stock into common stock (in shares) (856) (690,788)        
Exercise of warrants into common stock (in shares)   160        
Foreign currency translation adjustment       (2,064)   (2,064)
Net loss         (2,400) (2,400)
Ending Balance at Jun. 30, 2025     123,201 (4,174) (119,154) (127)
Ending Balance (in shares) at Jun. 30, 2025   4,441,165        
Stock-based compensation expense     261     261
Issuance of common stock to vendor     34     34
Issuance of common stock to vendor (in shares)   30,000        
Exercise of warrants into common stock   $ 1 (1)      
Exercise of warrants into common stock (in shares)   1,133,878        
Foreign currency translation adjustment       800   800
Net loss         (3,920) (3,920)
Ending Balance at Sep. 30, 2025   $ 1 $ 123,495 $ (3,374) $ (123,074) $ (2,952)
Ending Balance (in shares) at Sep. 30, 2025   5,605,043